Aplikace z oblasti Farmaceutická analýza se zaměřením na LC/TOF - strana 9
Otevřít dokument Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LCMS
Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
LCMS
Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
LCMS
Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LCMS
LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
LCMS
Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Spotřební materiál, LC kolony
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Spotřební materiál, LC kolony
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument A Comprehensive Software Ecosystem for End-to-End Monoclonal Antibody and Antibody–Drug Conjugate Data Acquisition, Analysis, and Reporting
LCMS
A Comprehensive Software Ecosystem for End-to-End Monoclonal Antibody and Antibody–Drug Conjugate Data Acquisition, Analysis, and Reporting
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Identification of Isomeric Amino Acids In The Antigen Binding Region Of A Monoclonal Antibody By Electron Capture Dissociation
LCMS
Identification of Isomeric Amino Acids In The Antigen Binding Region Of A Monoclonal Antibody By Electron Capture Dissociation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Proteomika, Farmaceutická analýza
Otevřít dokument Evaluation of New Peak Detection Performance in MAM Using a Controlled Peptide Spike-in Strategy
LCMS
Evaluation of New Peak Detection Performance in MAM Using a Controlled Peptide Spike-in Strategy
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Automated LC/MS System Readiness Assessment for MAM Using Purpose Designed Peptide Standards
LCMS
Automated LC/MS System Readiness Assessment for MAM Using Purpose Designed Peptide Standards
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Amino Acid Sequence Analysis of Semaglutide
LCMS
Amino Acid Sequence Analysis of Semaglutide
MALDI, LC/MS, LC/TOF
Instrumentace
MALDI, LC/MS, LC/TOF
Výrobce
Shimadzu
Zaměření
Farmaceutická analýza
